About
Visiting the laboratory in England, August 2021
Visiting the laboratory in England, August 2021
2021
Expansion
Staff 250 Opening of our lab in UK.
Launch of Trucheck™.
2020
Covid Year
Foundation of Datar Cancer Genetics UK Pvt Ltd in UK.
COVID Test Center in India.
2019
New Frontiers
6/7 clinical trials for outcome based investigations were started; CLIA approval; trublood large scale validation and launch.
Datar Cancer Genetics Europe GmbH in Germany
2018
Growth
Staff 170, global expansion, RESILIENT trial.
2017
New Brand
Renamed organization as Datar Cancer Genetics Ltd, CAP accreditation. Initiated pilot studies to establish outcome based clinical utility of exacta
2015
Oncology
ISO 15189 and NABL accreditation, launch of cancertrack and exacta.
2013
Launch
Incorporated in 2013 with a staff strength of 30 in Nashik, India. Focus on personal genome analysis.